WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABEO

Based on 1 analyst offering 12 month price targets for Abeona Therapeutics Inc.
Min Forecast
$38.00+462.96%
Avg Forecast
$38.00+462.96%
Max Forecast
$38.00+462.96%

Should I buy or sell ABEO stock?

Based on 1 analyst offering ratings for Abeona Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABEO stock forecasts and price targets.

ABEO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-08-24

1 of 1

Forecast return on equity

Is ABEO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
24.42%

Forecast return on assets

Is ABEO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ABEO revenue forecast

What is ABEO's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$13.5M+278.36%
Avg 2 year Forecast
$46.6M+1,204.65%
Avg 3 year Forecast
$87.4M+2,349.55%
ABEO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ABEO revenue growth forecast

How is ABEO forecast to perform vs Biotechnology companies and vs the US market?
Company
187.93%
Industry
48.24%
Market
9.9%
ABEO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ABEO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ABEO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABEO$6.75$38.00+462.96%Strong Buy
FGEN$1.72N/AN/A
GLSI$13.16$36.00+173.56%Buy
MESO$2.03$68.00+3,249.75%Strong Buy
TRVI$2.65N/AN/A

Abeona Therapeutics Stock Forecast FAQ

Is Abeona Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ABEO) stock is to Strong Buy ABEO stock.

Out of 1 analyst, 1 (100%) are recommending ABEO as a Strong Buy, 0 (0%) are recommending ABEO as a Buy, 0 (0%) are recommending ABEO as a Hold, 0 (0%) are recommending ABEO as a Sell, and 0 (0%) are recommending ABEO as a Strong Sell.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.

What is ABEO's revenue growth forecast for 2024-2026?

(NASDAQ: ABEO) Abeona Therapeutics's forecast annual revenue growth rate of 187.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.9%.

Abeona Therapeutics's revenue in 2024 is $3,568,000.On average, 2 Wall Street analysts forecast ABEO's revenue for 2024 to be $334,439,780, with the lowest ABEO revenue forecast at $272,506,487, and the highest ABEO revenue forecast at $396,373,072. On average, 2 Wall Street analysts forecast ABEO's revenue for 2025 to be $1,153,197,906, with the lowest ABEO revenue forecast at $1,090,025,948, and the highest ABEO revenue forecast at $1,216,369,865.

In 2026, ABEO is forecast to generate $2,165,187,906 in revenue, with the lowest revenue forecast at $2,165,187,906 and the highest revenue forecast at $2,165,187,906.

What is ABEO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ABEO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ABEO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ABEO price target, the average ABEO price target is $38.00, with the highest ABEO stock price forecast at $38.00 and the lowest ABEO stock price forecast at $38.00.

The Wall Street analyst predicted that Abeona Therapeutics's share price could reach $38.00 by Aug 24, 2024. The average Abeona Therapeutics stock price prediction forecasts a potential upside of 462.96% from the current ABEO share price of $6.75.

What is ABEO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ABEO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.